Word

SYNVENT

Status

Dead

Status Code

602

Status Date

Tuesday, October 13, 2020

Serial Number

88743029

Mark Type

3000

Filing Date

Tuesday, December 31, 2019

Abandoned Date

Tuesday, September 29, 2020

Trademark Owner History

Syngene International Limited

Classifications

1 Bio-technological products including, enzymes, protein carbohydrates, lipids, and nucleic acids, DNA products, immunological re-agents, and fine chemicals including organic intermediates; active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions; chemicals for use in the agrochemical industry; assays for research purposes; biomedical compounds, namely, peptide substrates used in analysing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; chemical polymers; chemicals for use in biotechnological product development; chemicals, namely, chitosan; chitosan for industrial purposes; aldehydes; chromatography chemicals; cells for scientific, laboratory or medical research; reagents for use in the development of hybridoma antibodies; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; protein arrays and nucleotide arrays for scientific and medical research; peptides for industrial purposes; proteins for use in recombinant dna technology; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; assays for research purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology

5 Bio-logical and bio-technological products pertaining to pharmaceutical and medical industries and formulations thereof; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies; synthetic peptides for pharmaceutical purposes; aldehydes for pharmaceutical purposes; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; vascular grafts; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; proteins for use in recombinant DNA technology; regulatory proteins for medical use; medicines for veterinary purposes; isotopes for medical purposes; biological preparations for medical purposes; chemical preparations for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids

42 Scientific research and custom synthesis included in class 42; scientific and clinical research included in class 42; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing; laboratory testing services; testing of pharmaceuticals; chemical engineering; behavioural analysis of chemicals; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; clinical trials (conducting); conducting clinical trials for others; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, agrochemical pharmaceuticals, bioinformatics, biomedical, biologics, biotechnology, biotherapeutics, biology, biochemical, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, solid state characterization; toxicokinetic, toxicology; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibody, API, biomolecules, cell bank characterization, chiral, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, gene, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbial, monomer, nanoparticle, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines

44 Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services

Color is not claimed as a feature of the mark.
The mark consists of the word "SYNVENT" in stylized letters with the "V" in a circle.

Trademark Events

Oct 13, 2020

Abandonment Notice E-Mailed - Failure To Respond

Oct 13, 2020

Abandonment - Failure To Respond Or Late Response

Mar 27, 2020

Notification Of Non-Final Action E-Mailed

Mar 27, 2020

Non-Final Action E-Mailed

Mar 27, 2020

Non-Final Action Written

Mar 24, 2020

Assigned To Examiner

Jan 8, 2020

Notice Of Design Search Code E-Mailed

Jan 7, 2020

New Application Office Supplied Data Entered In Tram

Jan 3, 2020

New Application Entered In Tram